Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Vaccine Recommendations and Guidelines of the ACIP








DTaP/Tdap/Td ACIP Vaccine RecommendationsAdvisory Committee on Immunization Practices (ACIP)						Print
																Related Pages
										On This Page
			Current RecommendationsArchived
Published in Morbidity and Mortality Weekly Report (*MMWR*)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT DTaP/Tdap/Td Vaccine Recommendations
*MMWR*, January 24, 2020, Vol 69(3);77-83Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
Print version [7 pages]*MMWR*, April 27, 2018, Vol 67, (RR-2);1-44Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Print version [48 pages]See also:
ACIP VFC Resolution
ARCHIVED Historical DTaP/Tdap/Td Vaccine Recommendations
For your convenience, these archived publications can be used for historical and research purposes.
*MMWR*, September 4, 2015, Vol 64(34);948-949Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose
Print version [36 pages]
*MMWR*, September 23, 2011, Vol 60(37);1279-1280FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Print versio [1.59MB, 32 pages]
*MMWR*, January 14, 2011, Vol 60(01);13-15Updated Tdap Vaccine Recommendations from the ACIP, 2010
Print versio [1.18MB, 36 pages]
*MMWR*, April 17, 2009, Vol 58(14);374-375FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Print version [2.07MB, 32 pages]
*MMWR*, August 1, 2008, Vol 57(RR-06);1-19Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events — United States, 2008
Print version [28 pages]
*MMWR*, December 9, 2005, Vol 54(RR-14);1-16Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis: 2005 CDC Guidelines
Print version [20 pages]
*MMWR*, September 26, 2003, Vol 52(38);921-921*Notice to Readers*: FDA Approval of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, (INFANRIX®) for Fifth Consecutive DTaP Vaccine Dose
Print version [32 pages]
*MMWR*, November 17, 2000, Vol 49(RR-13);1-8Use of DTaP (Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis) Vaccine as a Five-Dose Series
Print version [7 pages]
*MMWR*, August 8, 1991, Vol 40(RR-10);1-28Diphtheria, Tetanus, and Pertussis: Recommendations for Vaccine Use and Other Preventive Measures(PDF not available)Adolescents
*MMWR*, March 24, 2006, Vol 55(RR-03);1-34Preventing Tetanus, Diphtheria, and Pertussis Among ADOLESCENTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
Appendix A | Appx B | Appx C | Appx D | Appx E | Appx FNote: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes 6 important appendices.
Print version[50 pages] (includes appendices)Adults (under 65 years old)
*MMWR*, December 15, 2006, Vol 55(RR-17);1-33Preventing Tetanus, Diphtheria, and Pertussis Among ADULTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
Appendix A | Appendix B | Appendix CNote: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes important appendices.
Print version[44 pages]Adults 65 years and older
*MMWR*, June 29, 2012, Vol 61(25);468-470Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012
Print version [20 pages]Infants and Young Children
*MMWR*, March 14, 2003, Vol 52(10);203-204*Notice to Readers*: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIXTM) for Use in Infants [24 pages]
Print version [24 pages]
*MMWR*, July 5, 2002, Vol 51(26);574*Notice to Readers*: Food and Drug Administration Approval of a Fifth Acellular Pertussis Vaccine for Use Among Infants and Young Children — United States, 2002
Print version [24 pages]
*MMWR*, March 28, 1997, Vol 46(RR-7);1-25Pertussis Vaccination: Use of Acellular Pertussis Vaccines Among Infants and Young Children
Print version [32 pages]Pregnancy Immunization
*MMWR*, February 22, 2013, Vol 62(07);131-135Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women – ACIP, 2012
Print version [1.11MB, 28 pages]
*MMWR*, October 21, 2011, Vol 60(41);1424-1426Updated Recommendations for Use of Tdap in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months – ACIP, 2011
Print version [32 pages]
*MMWR*, May 30, 2008, Vol 57 (04);1-47,51Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants
Appendix A | Appendix B
Print version [56 pages] (includes appendices)Top of Page
							
					
							Last Reviewed:  December 12, 2023						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeACIP Recs Home
Vaccine-Specific Recommendationsplus icon
Anthrax
Cholera
COVID-19
Dengue
DTaP/IPV/Hib/HepB
DTaP/Tdap/Td
Ebola
Hepatitis A
Hepatitis B
Hib
HPV
Influenza
Japanese Encephalitis
MMR
MMRV
Meningococcal
Pneumococcal
Polio
Rabies
Rotavirus
RSV
Smallpox
TBE
Typhoid
Varicella
Yellow Fever
Zoster (Shingles)
Recs Listed by Date
Comprehensive Recommendations and Guidelinesplus icon
General Best Practice Guidelinesplus icon
Introduction
History
Timing and Spacing of Immunobiologics
Contraindications and Precautions
Preventing and Managing Adverse Reactions
Vaccine Administration
Storage and Handling of Immunobiologics
Altered Immunocompetence
Special Situations
Vaccinations Records
Vaccination Programs
Vaccine Information Sources
Appendix 1: Glossary
Appendix 2: Membership
Archived ACIP Recs
Vaccine Recommendations for Emergency Situations To receive email updates about this page, enter your email address: Email Address			What's this?				Submit
 Vaccines & ImmunizationsVFC ResolutionsACIP Web SiteCDC's International Travelers Yellow BookClinical Travel Notices, Updates, and Vaccine Shortages


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue